available data – Page 36 – Communicable Diseases Research

Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019

코로나바이러스 2019에 렘데시비르를 사용한 간 장애

Multicenter Study

Published on 2020-11-012022-09-11
Journal: Clinical gastroenterology and hepatology : the off [Category] Coronavirus, SARS, 비임상,

[키워드] Adverse drug reaction adverse event adverse events Aminotransferase antiviral activity available data Bilirubin breath broad spectrum Cell culture cell cultures clinical development clinical trials Cohort studies cohort study compassionate-use coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients disorder double-blind drug drug reaction Drug-induced liver injury elevated EMA European Medicines Agency FDA food healthy volunteer healthy volunteers hepatic hepatic enzyme hepatic enzymes hepatotoxicity hospital human coronavirus increase Infection Intravenous remdesivir investigator investigators Liver injury mouse model Mouse models nucleotide Patient patients hospitalized patients with COVID-19 Placebo placebo recipient placebo recipients placebo-controlled clinical trial proportion raised Randomized recipient Remdesivir reported respiratory safety profile Severe acute respiratory syndrome Severe Acute Respiratory Syndrome-associated Coronavirus 2 severe coronavirus disease severe COVID-19 treated Treatment
[DOI] 10.1016/j.cgh.2020.07.050 PMC 바로가기 [Article Type] Multicenter Study

The first wave of COVID-19 in Israel—Initial analysis of publicly available data

Research Article

Published on 2020-10-292022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] accompanied Analysis available data confirmed case COVID-19 decrease doubling European country exceeded extreme First wave Government Greece infection rate Intervention Italy less lifted Local lockdown measure Measures media suggested
[DOI] 10.1371/journal.pone.0240393 PMC 바로가기 [Article Type] Research Article

The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19

Immunology

Published on 2020-10-282022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] Affect AID Athletes available data boost immunity category Cold common Concentration conditions COVID-19 Critical diabetics Effect frail elderly subjects General population Health high risk High-dose history hospitalized patients immune function immune response immune system Infection infections Inflammation Long modulate non-communicable diseases obese physiological plasma Pneumonia positive Potential prevention recommendation reduce Respiratory disease respiratory infection risk SARS-CoV2 infection significantly subgroup subject Support susceptibility Treatment treatment for COVID-19 viral infections Vitamin Vitamin C vitamin C supplementation
[DOI] 10.3389/fimmu.2020.574029 PMC 바로가기 [Article Type] Immunology

The Importance of Research on the Origin of SARS-CoV-2

Editorial

Published on 2020-10-222022-10-28
Journal: Viruses [Category] COVID-19, Fulltext, MERS, SARS, 조류인플루엔자,

Neurological manifestations in coronavirus disease 2019 (COVID-19) patients: a systematic review of literature

Review

Published on 2020-10-212022-10-31
Journal: CNS Spectrums [Category] COVID-19, MERS,

[키워드] Affect Analysis ARDS article available data cause CNS controlled trials Corona virus coronavirus disease COVID-19 COVID-19 patients COVID-19 severity database diagnosed with COVID-19 Dizziness eligibility excluded glial cell headache highest incidence induce Infection limitations manifestation neurological Neurological complication neurological manifestation neurological manifestations Neurological symptom Neuron nonrandomized objective observational study occur Participants Pathologies Patient patients Pediatric patient reported representing Result SARS-CoV2 Severe patient Symptom systematic literature search systematic review the disease virus was performed
[DOI] 10.1017/S1092852920001935 PMC 바로가기 [Article Type] Review

Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study

미국의 연령별 COVID-19 사망률의 인종/민족 격차 변화: 횡단면 연구

Research Article

Published on 2020-10-202022-08-13
Journal: PLoS Medicine [Category] COVID-19, Medicine and Health Sciences, MERS, SARS,

[키워드] 95% CI addition Adults age age standardization age-specific mortality Alaska Analysis Asian available data black calculate census center color Control Coverage COVID-19 COVID-19 mortality cross-sectional cross-sectional study death Death certificates determine disease control Enhancing examination extreme group groups Health health department Hispanic include Infection life limitation Local measure media Mortality mortality rate mortality rates mortality risk much higher National Native number of deaths occurred Older Population population sizes populations prevention prevention of COVID-19 Racial ranged rate ratio rate ratios receipt released reported researcher risk of death Standardization Support The United States These data Transmission United States Variation white
[DOI] 10.1371/journal.pmed.1003402 PMC 바로가기 [Article Type] Research Article

Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic

Review article

Published on 2020-10-172022-10-05
Journal: Informatics in Medicine Unlocked [Category] 신약개발, 유전자 메커니즘, 치료제,

Predicting thromboembolic complications in COVID-19 ICU patients using machine learning

Original Article

Published on 2020-10-142022-10-29
Journal: Journal of Clinical and Translational Research [Category] COVID-19,

[키워드] age albumin analyzed artificial intelligence association available data center Classifier clinical decision clinical impact clinician control group coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Critical Critically ill decision determine develop Erasmus University Factor Generalizability Health Hemostasis hypercoagulability ICU ICU patient ICU treatment identify IMPROVE intensive care unit intensive care units interquartile range leukocyte likelihood ratio machine learning male management median occur outcome pandemic Patient positive predicted predictor Prognosis progressive respiratory failure Pulmonary embolism Relevance risk sensitivity test dataset therapeutic anticoagulation thromboembolic complication tree
PMC 바로가기 [Article Type] Original Article

Self-Quarantine Noncompliance During the COVID-19 Pandemic in South Korea

Brief Report

Published on 2020-10-122022-10-31
Journal: Disaster Medicine and Public Health Preparedness [Category] COVID-19, MERS,

Pathophysiology of Cardiovascular Complications in COVID-19

Physiology

Published on 2020-10-092022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] addition available data cardiometabolic conditions cardiovascular cardiovascular complication cardiovascular complications cardiovascular disease chronic cardiovascular Clinical course coagulation disorder Comorbidity Complication COVID-19 CVD Cytokine release syndrome de novo disease driving dysregulation Follow-up identify increased risk increasingly Infection Inflammatory Injury molecular Mortality Numerous older population pathophysiology pathway Patient patients with COVID-19 pediatric Pediatric Inflammatory Multisystem Syndrome protocol RAAS risk risk factor SARS-CoV-2 virus shown syndrome targets thrombosis treat Treatment with COVID-19
[DOI] 10.3389/fphys.2020.575600 PMC 바로가기 [Article Type] Physiology